Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
MSD
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
NEW YORK, September 18, 2026--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 9/30/26 10/15/26 Name of Closed-End Fund NYSE Ticker Net…
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
NEW YORK, June 18, 2026--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 6/30/26 7/15/26 Name of Closed-End Fund NYSE Ticker Net Inves…
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
NEW YORK, March 20, 2026--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 3/31/2026 4/15/2026 Name of Closed-End Fund NYSE Ticker Net…
Turbine Secures $25M Series B Led by Interactive Venture Partners with participation from Beiersdorf Venture Capital, Announces First Immunology Partnership with Top 10 Pharma Company
LONDON and BUDAPEST, Hungary, Feb. 24, 2026 /PRNewswire/ -- Turbine, a leading virtual biology company, today announced a $25 million Series B financing, an expansion of its virtual cell platform across industries and a new immunology-focu…
Pharma eyes AI deals to stem lost revenues from patent expirations
Pharmaceutical giants are employing an array of tactics to minimise the falling revenues that come when patents expire on their top drugs. Among these, experts say artificial intelligence (AI) is playing a growing and potentially revolutio…
Kelun-Biotech Showcases Innovative Achievements and Future Development Strategy at the 44th Annual JPM Healthcare Conference
CHENGDU, China, Jan. 16, 2026 /PRNewswire/ -- From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and CEO of Sichuan Kelun-Biotech Biopharmac…
MSD initiates construction on $3bn Virginia drug manufacturing site
Merck & Co (MSD) has broken ground on its new pharmaceutical manufacturing Centre of Excellence in Virginia, US, amid looming tariff threats from the Trump administration. The $3bn site, which is located at the pharma’s Elkton facility, wi…
Merck Manuals Shares What Patients Need to Know About COPD
RAHWAY, N.J., Oct. 2, 2025 /PRNewswire/ -- Chronic obstructive pulmonary disease (COPD) is a leading cause of death in many smokers and former smokers.MerckManuals.com (PRNewsfoto/MerckManuals.com) While living with the condition, there ar…
Morgan Stanley Emerging Markets Debt Fund declares $0.17 dividend
* Morgan Stanley Emerging Markets Debt Fund (NYSE:MSD [https://seekingalpha.com/symbol/MSD]) declares $0.17/share quarterly dividend [https://seekingalpha.com/pr/20238772-certain-morgan-stanley-closed-end-funds-declare-quarterly-dividends]…
MSD calls off £1bn UK expansion amid government-big pharma tensions
Merck & Co (MSD) has ditched plans for its £1bn R&D centre in London, UK, while ceasing drug discovery and research efforts across the country in a double blow to the national life sciences sector. This news comes fewer than two years afte…
Merck’s move to axe £1bn UK expansion was ‘commercial decision’, says minister
The Government has insisted US drugs giant Merck’s move to ditch plans for a £1 billion London centre was a “commercial decision” as it came under fire for under-investment in the sector. Merck, known as MSD in the UK and Europe, dealt a m…
US drugmaker scraps plans for £1bn UK research centre
One of America’s largest drug companies has ditched plans to open a £1bn research centre in London amid a growing row with the Government over surging NHS charges. Merck, which makes cancer drugs, said it would no longer open a new researc…
Merck Demonstrates Ongoing Commitment to Advancing Cardiovascular Disease Management and Patient Care with New Data at the European Society of Cardiology Congress 2025
New real-world evidence and clinical trial data provide insights into treatment patterns for several serious cardiovascular diseases, including ASCVD, PH, and HFrEF RAHWAY, N.J., August 25, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known a…
PANTHERx® Rare Selected by Insmed to Dispense BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
PITTSBURGH, Aug. 13, 2025 /PRNewswire/ -- PANTHERx® Rare Pharmacy, a leader in rare disease product patient access and support services in the United States, announced that it was selected by Insmed as part of the network of specialty phar…
Livestock Monitoring Company Evaluation Report 2025 | Merck & Co., GEA Group, and DeLaval Drive Global Innovations Across Biopharma, Process Technology, and Dairy Farming Automation
Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Livestock Monitoring - Company Evaluation Report, 2025" has been added to ResearchAndMarkets.com's offering. The Livestock Monitoring Companies Quadrant is a comprehensive industry analysis th…
Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates
Adagene Inc. Muzastotug (ADG126) Phase 1b/2 in MSS CRC shows 19.4-month median OS (mOS) in 10 mg/kg dose cohorts; mOS for 20 mg/kg cohorts has not yet been reached Alignment with FDA on Phase 2 and Phase 3 trial design elements. Company ex…
IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (Pembrolizumab) for the Treatment of First-line Advanced Melanoma, but Statistical Significance Narrowly Missed
IO Biotech Patients treated with Cylembio (imsapepimut and etimupepimut, adjuvanted) plus pembrolizumab achieved improvement in progression free survival (PFS) compared to patients treated with pembrolizumab monotherapy, HR=0.77 (CI 0.58-1…
Turbine to Simulate Hard-to-Treat Cancer Populations with AI for Identification of Novel Dependencies through Collaboration with MSD
LONDON, UK and BUDAPEST, HUNGARY, Aug. 4, 2025 /PRNewswire/ -- Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ USA) to create simula…
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
NEW YORK, June 20, 2023--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 6/30/23 7/14/23 Name of Closed-End Fund NYSE Ticker Net Inves…
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
NEW YORK, March 21, 2023--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 3/31/23 4/14/23 Name of Closed-End Fund NYSE Ticker Net Inve…
Certain Morgan Stanley Closed-End Funds Declare Year-End Dividends
NEW YORK, December 06, 2022--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 12/16/22 1/13/23 Name of Closed-End Fund NYSE Ticker Net…
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
NEW YORK, September 20, 2022--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE 9/30/22 PAYABLE DATE 10/14/22 Name of Closed-End Fund NYSE Ticker Net…
Morgan Stanley Investment Management Announces Portfolio Management Change for Morgan Stanley Emerging Markets Debt Fund, Inc. and Morgan Stanley Emerging Markets Domestic Debt Fund, Inc.
NEW YORK, July 19, 2022--(BUSINESS WIRE)--Morgan Stanley Investment Management announced today a portfolio management change for Morgan Stanley Emerging Markets Debt Fund, Inc. (NYSE: MSD) and Morgan Stanley Emerging Markets Domestic Debt…
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
NEW YORK, June 17, 2022--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE 6/30/22 PAYABLE DATE 7/15/22 Name of Closed-End Fund NYSE Ticker Net Inves…
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
NEW YORK, March 21, 2022--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 3/31/22 4/14/22 Name of Closed-End Fund NYSE Ticker Net Inve…
Certain Morgan Stanley Closed-End Funds Declare Year-End Dividends
NEW YORK, December 07, 2021--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE 12/17/21 PAYABLE DATE 1/14/22 Name of Closed-End Fund NYSE Ticker Net…
Morgan Stanley Investment Management Announces Portfolio Management Change for Morgan Stanley Emerging Markets Debt Fund, Inc. and Morgan Stanley Emerging Markets Domestic Debt Fund, Inc.
NEW YORK, November 15, 2021--(BUSINESS WIRE)--Morgan Stanley Investment Management announced today a portfolio management change for Morgan Stanley Emerging Markets Debt Fund, Inc. (NYSE: MSD) and Morgan Stanley Emerging Markets Domestic D…
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
NEW YORK, September 20, 2021--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 9/30/21 10/15/21 Name of Closed-End Fund NYSE Ticker Net…
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
NEW YORK, Jun 18, 2021--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 6/30/21 7/15/21 Name of Closed-End Fund NYSE Ticker Net Invest…
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
NEW YORK, Jun 18, 2021--(BUSINESS WIRE)--Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 6/30/21 7/15/21 Name of Closed-End Fund NYSE Ticker Net Invest…
Certain Morgan Stanley Closed-End Funds Declare Quarterly Dividends
Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 3/31/21 4/15/21 Name of Closed-End Fund NYSE Ticker Net Investment Income Per Share Morgan Stanley Emer…
Certain Morgan Stanley Closed-End Funds Declare Year-End Dividends
Each of the Morgan Stanley closed-end funds listed below (the "Funds") today declared the following dividends. RECORD DATE PAYABLE DATE 12/18/20 1/15/21 Name of Closed-End Fund NYSE Ticker Net Investment Income Per Share Morgan Stanley Eme…